Depreciation of Achilles Therapeutics plc from 31 Dec 2019 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Achilles Therapeutics plc quarterly and annual Depreciation in USD history and change rate from 31 Dec 2019 to 30 Jun 2024.
  • Achilles Therapeutics plc Depreciation for the quarter ending 30 Jun 2024 was $1,200,000, a 7.7% decline year-over-year.
  • Achilles Therapeutics plc annual Depreciation for 2023 was $4,700,000, a 27% increase from 2022.
  • Achilles Therapeutics plc annual Depreciation for 2022 was $3,700,000, a 12% increase from 2021.
  • Achilles Therapeutics plc annual Depreciation for 2021 was $3,300,000, a 312% increase from 2020.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Achilles Therapeutics plc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $1,200,000 -$100,000 -7.7% 01 Apr 2024 30 Jun 2024 6-K 14 Aug 2024 2024 Q2
Q2 2023 $1,300,000 +$400,000 +44% 01 Apr 2023 30 Jun 2023 6-K 14 Aug 2024 2024 Q2
Q2 2022 $900,000 01 Apr 2022 30 Jun 2022 6-K 04 Aug 2023

Achilles Therapeutics plc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $4,700,000 +$1,000,000 +27% 01 Jan 2023 31 Dec 2023 20-F 04 Apr 2024 2023 FY
2022 $3,700,000 +$400,000 +12% 01 Jan 2022 31 Dec 2022 20-F 04 Apr 2024 2023 FY
2021 $3,300,000 +$2,500,000 +312% 01 Jan 2021 31 Dec 2021 20-F 04 Apr 2024 2023 FY
2020 $800,000 +$500,000 +167% 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023 2022 FY
2019 $300,000 01 Jan 2019 31 Dec 2019 20-F 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.